Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,773,979
  • Shares Outstanding, K 51,105
  • Annual Sales, $ 870,460 K
  • Annual Income, $ 79,470 K
  • 60-Month Beta 0.28
  • Price/Sales 3.22
  • Price/Cash Flow 13.59
  • Price/Book 4.00
Trade HAE with:

Options Overview Details

View History
  • Implied Volatility 50.71%
  • Historical Volatility 47.67%
  • IV Percentile 79%
  • IV Rank 38.68%
  • IV High 83.72% on 04/19/21
  • IV Low 29.88% on 12/15/20
  • Put/Call Vol Ratio 0.47
  • Today's Volume 63
  • Volume Avg (30-Day) 276
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 2,710
  • Open Int (30-Day) 2,815

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate 0.75
  • Number of Estimates 4
  • High Estimate 0.80
  • Low Estimate 0.71
  • Prior Year 0.81
  • Growth Rate Est. (year over year) -7.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
50.12 +10.63%
on 12/01/21
63.50 -12.68%
on 11/09/21
-15.68 (-22.04%)
since 11/08/21
3-Month
50.12 +10.63%
on 12/01/21
75.34 -26.40%
on 11/08/21
-7.87 (-12.43%)
since 09/08/21
52-Week
49.26 +12.57%
on 05/13/21
142.11 -60.98%
on 02/09/21
-59.61 (-51.81%)
since 12/08/20

Most Recent Stories

More News
January 2022 Options Now Available For Haemonetics (HAE)

Investors in Haemonetics Corp. saw new options begin trading today, for the January 2022 expiration.

HAE : 55.45 (+2.16%)
Haemonetics (HAE) Q2 Earnings Lag Estimates, Gross Margin Grows

Haemonetics (HAE) revenues increased year over year in the fiscal second quarter, supported by recovery across major businesses, especially Hospital and the initial Plasma Persona rollouts.

TMO : 638.15 (+1.50%)
HAE : 55.45 (+2.16%)
WST : 435.51 (+1.29%)
MEDP : 213.65 (-0.01%)
Haemonetics (HAE) Lags Q2 Earnings and Revenue Estimates

Haemonetics (HAE) delivered earnings and revenue surprises of -4.76% and -2.44%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

HAE : 55.45 (+2.16%)
Haemonetics: Fiscal Q2 Earnings Snapshot

BOSTON (AP) _ Haemonetics Corp. (HAE) on Tuesday reported fiscal second-quarter earnings of $14.9 million.

HAE : 55.45 (+2.16%)
Haemonetics (HAE) Earnings Expected to Grow: Should You Buy?

Haemonetics (HAE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HAE : 55.45 (+2.16%)
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2022 Results: November 9, 2021

/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2022 financial results at 6:00 am...

HAE : 55.45 (+2.16%)
Here's Why You Should Retain Haemonetics (HAE) Stock for Now

Investors are optimistic about Haemonetics (HAE) on strong demand for NexSys PCS system and potential of Hemostasis Management franchise.

MCK : 226.68 (+0.94%)
HAE : 55.45 (+2.16%)
ALC : 85.24 (+2.26%)
BIOL : 0.4338 (+5.52%)
Haemonetics (HAE) Rides on Plasma Arm Recovery Amid COVID Woes

Haemonetics' (HAE) hospital business is recovering primarily driven by continued improvement in hospital procedures.

MCK : 226.68 (+0.94%)
HAE : 55.45 (+2.16%)
ALC : 85.24 (+2.26%)
BIOL : 0.4338 (+5.52%)
ADMA Biologics Advances Expansion Plans and Opens New Plasma Collection Center in Conyers, GA; ADMA Implements Haemonetics’ Persona Technology for NexSys Plasma Collection System

RAMSEY, N.J. and BOCA RATON, Fla. and CONYERS, Ga., Aug. 10, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to...

HAE : 55.45 (+2.16%)
ADMA : 1.3800 (+1.47%)
Caesars, Boot Barn rise; Haemonetics, Utz Brands fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Thursday:

STZ : 234.68 (+0.36%)
SONO : 31.42 (+1.49%)
NUE : 112.81 (-1.05%)
BOOT : 128.49 (+1.65%)
DOX : 71.16 (+0.55%)
HAE : 55.45 (+2.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Haemonetics Corporation is a Global Leader in Blood Management Solutions. Their comprehensive portfolio of devices, information management, consulting services offers blood management solutions for each facet of the blood supply chain from plasma blood collectors to hospitals. They believe that through...

See More

Key Turning Points

3rd Resistance Point 58.00
2nd Resistance Point 56.86
1st Resistance Point 56.16
Last Price 55.45
1st Support Level 54.32
2nd Support Level 53.18
3rd Support Level 52.48

See More

52-Week High 142.11
Fibonacci 61.8% 106.64
Fibonacci 50% 95.68
Fibonacci 38.2% 84.73
Last Price 55.45
52-Week Low 49.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar